The Spanish program for rare blood donors by Muñiz-Diaz, Eduardo et al.
IMMUNOHEMATOLOGY, Volume 32, Number 2, 2016 59
The Spanish program for rare blood donors
E. Muñiz-Diaz, A. Castro, E. Flores, L. Larrea, F. Puente, M. Ayape, and M.A. Pérez-Vaquero*
Review
The Spanish program for rare blood donors was created 
in 2005. Before that year, no official program existed and no 
government measure had been taken to create a program 
for providing rare blood for patients in need. To better 
understand the origin, history, and outcome of our program, 
it is necessary to understand how Spain is organized from a 
political and administrative point of view. Spain is divided into 
17 autonomous regions, each with its own government and 
health care, making health care in Spain highly decentralized. 
The regional governments are in charge of managing their 
own health services and work as competent authorities as 
part of the National Network of Blood Establishments and 
Hospital Transfusion Services. The Ministry of Health, in 
Madrid, coordinates the functions of the whole health care 
structure and works as the competent authority for many 
responsibilities, including managing the relationship with 
the European Union. About 2 million blood components were 
transfused in Spain in 2014. All these units were collected, 
processed, and distributed by 24 blood transfusion centers 
(BTCs) and were transfused at 400 hospitals throughout the 
country.
For several years, four BTCs, each from a different region, 
had been working on the collection and the cryopreservation 
of red blood cells (RBCs) with rare phenotypes (Catalonia, 
Galicia, Madrid, and Valencia), and a fifth center (Navarra) 
participated by providing a list of donors with rare phenotypes. 
All this work was undertaken on the initiative of these 
BTCs, given the absence of a national policy concerning the 
collection, maintenance, and provision of rare blood. At that 
time, each center knew what units it had at its disposal, but 
this information was not available to the public. No one in the 
country knew the total number of cryopreserved units, the 
total number of rare blood donors, or the antigenic profiles of 
these units and donors. Finally, at the end of 2005, the Spanish 
program for rare blood donors was established, consisting 
of the five BTCs involved in the management of rare blood 
phenotypes. Additionally, the group requested the support of 
the Spanish Society of Blood Transfusion (SETS), who agreed 
and suggested that the cooperative group should be constituted 
as a Working Party of SETS.
A year later, the national stock of cryopreserved units with 
rare blood types (consisting of 658 units) was published for 
the first time. Since then, this information has been updated 
and published every year in the SETS journal and on the 
Web site of our Society. The list and the phenotype profile of 
the 766 cryopreserved rare units of blood currently available 
are shown in Table 1. In addition, the program has a list of 
900 rare blood donors willing to give blood in emergency 
cases. This list needs to be upgraded, however, to distinguish 
between two types of donors: (1) donors willing to give blood 
after being informed about their rare phenotype and (2) donors 
with a rare phenotype but who have not yet been informed. In 
practice, only the first group of donors should be included in 
our reports.
To make the service more workable and more uniform, a 
protocol for requesting rare blood units was established. This 
protocol includes the Requesting Form and the Receiving 
Form; both forms are available from the Web site of our Society. 
The Requesting Form consists of two parts: one part concerns 
the details of the requesting center and the other part deals 
with the details of the patient (e.g., phenotype of the RBCs 
requested, number of units, and the preferred mode of units 
requested [cryopreserved, thawed, or fresh]). The Receiving 
Form, inspired by the form originally designed by the Working 
Party on Rare Donors of the International Society of Blood 
Transfusion (ISBT), also consists of two parts: one concerns 
the shipping center and the other concerns the patient (e.g., 
whether or not the units arrived in perfect condition [state 
of the bag, temperature, etc.]). Moreover, to provide a more 
efficient service, each BTC is responsible for the rare RBC 
units requested from a certain number of autonomous regions. 
The BTC of reference may request a sample from the hospital 
whenever it considers this to be necessary. If the units are 
not available in Spain, the BTC of Catalonia is responsible for 
obtaining the units from the International Rare Donor Panel 
(IRDP) in Bristol, United Kingdom. Our rare units of blood 
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were integrated into the IRDP in 2009 when the Spanish 
Working Party on Rare Donors became an official member.
Regarding the activity of our program, 246 rare units of 
blood were supplied in the period from 2010 to 2014: 122 of 
these units were thawed and 124 were fresh (Table 2). Twelve 
of these units were distributed in response to international 
requests: 1 Vel– (Israel), 5 Di(b–) (Sweden), 5 Jr(a–) (4 UK 
and 1 Sweden), and 1 D–– (Portugal).
In the last 10 years, all requests but one were filled. The 
only exception was the case of a woman with an antibody 
directed against a high-prevalence antigen for which the 
specificity had not been identified before transfusion. She 
was transfused with RBCs from her son and suffered from a 
moderate hemolytic transfusion reaction. Some months later, 
the International Blood Group Reference Laboratory (IBGRL) 
of Bristol (UK) identified a new specificity directed to a new 
antigen termed DOLC in her blood. This antigen belongs to the 
Dombrock system.
At present, we have no active Rhnull donors, but one donor 
and two patients had been identified in the past as carriers 
of this rare phenotype. The molecular background was 
investigated in one of the patients in whom a complete deletion 
of the RHAG gene was found. There are other phenotypes 
that are also very difficult to find in our country, such as K0, 
McLeod, Co(a–b–), GE:–2, GE:–2,–3, Rh17–, Rh29–, Cr(a–), 
In(b–), SC:–1, and At(a–).
In summary, the creation of this Working Party on Rare 
Donors in Spain has led to major improvements in recent 
years. In the last 2 years, two new BTCs (Aragon and Basque 
Country) have been incorporated into the Working Party, also 
providing a list of blood donors with rare phenotypes. Our 
panel of cryopreserved units currently includes 766 units, and 
the list of donors with rare blood types includes 900 blood 
donors. 
This impressive list of units and donors with rare 
phenotypes is the result of the great effort made by the different 
BTCs in the years before the creation of the Spanish Working 
Party. The union of all these efforts, together with the creation 
of the Spanish program for rare blood donors, allowed us to 
optimize the list of donors and units to improve the service we 
offer to hospitals and to patients. In recent years, our donors 
have shown a high level of commitment without any incentive 
E. Muñiz-Diaz et al.
Table 1. Inventory of cryopreserved units of rare blood in the Spanish program for rare blood donors, 2015
Phenotype A+ A– O+ O– AB+ AB– B+ B– Total
k– 25 18 86 60 0 0 0 0 189
Lu(a+b–) 12 2 38 43 1 0 0 0 96
Fy(a–b–) 8 1 32 38 0 0 0 0 79
PP1Pk– 17 0 32 5 1 0 19 0 74
Kp(a+b–) 12 0 15 38 0 1 0 3 69
Vel– 4 10 21 15 1 0 0 0 51
Co(a–) 5 0 25 4 0 0 0 0 34
Yt(a–) 6 3 17 6 0 0 0 0 32
r′r′ 0 9 0 19 0 0 0 0 28
Jr(a–) 5 0 8 9 0 0 0 0 22
Di(b–) 0 0 16 0 0 0 2 0 18
D–– 12 0 0 0 0 0 0 0 12
r″r″ 0 3 0 7 0 0 0 0 10
Lan– 0 0 6 2 0 0 0 0 8
U– 0 0 6 1 0 0 0 0 7
Jk(a–b–) 0 3 0 3 1 0 0 0 7
JMH– 0 0 5 1 0 0 0 0 6
S–s– 0 0 5 0 0 1 0 0 6
RzRz 0 0 6 0 0 0 0 0 6
Lu(a–b–) 0 0 4 0 0 0 0 0 4
Oh (Bombay) 0 0 4 0 0 0 0 0 4
r′r″ 0 0 0 2 0 0 0 0 2
K0 0 0 0 2 0 0 0 0 2
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other than the satisfaction of altruistically helping the patients 
needing a transfusion from a rare blood donor. We believe that 
the best way to achieve this level of commitment is to provide 
the donors with the most complete information possible about 
the significance of being a carrier of a rare blood group. 
To determine the efficient use of these special units of 
blood, further work is needed to reinforce the habit of reporting 
the final destination and outcome of the units supplied. 
Although our panel covers most of the phenotypes that are 
clinically important, we continue searching for others that are 
extremely rare due to their low prevalence. The ISBT Working 
Party should play a central role in coordinating the search for 
these very rare phenotypes with the different members.
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Table 2. Rare units of blood supplied by the Spanish program for 
rare blood donors, 2010–2014.
Phenotype Cryopreserved Fresh Total
Kp(a+b–) 48 23 71
k– 19 25 44
Vel– 5 22* 27
Lu(a+b–) 6 15 21
Fy(a–b–) 4 13 17
Yt(a–) 4 8 12
PP1Pk– 6 2 8
Jr(a–) 8‡ 0 8
U– 7 1 8
Co(a–) 2 5 7
Di(b–) 2 5† 7
RzRz 4 1 5
Oh (Bombay) 4 0 4
r′r′ 2 2 4
D–– 1§ 1 2
r″r″ 0 1 1
122 124 246
*1 Israel.
†4 UK, 1 Sweden.
‡5 Sweden.
§1 Portugal.
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